Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

741 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results.
Schultz LM, Jeyakumar N, Kramer AM, Sahaf B, Srinagesh H, Shiraz P, Agarwal N, Hamilton M, Erickson C, Jacobs A, Moon J, Baggott C, Arai S, Bharadwaj S, Johnston LJ, Liedtke M, Lowsky R, Meyer E, Negrin R, Rezvani A, Shizuru J, Sidana S, Egeler E, Mavroukakis S, Tunuguntla R, Gkitsas-Long N, Retherford A, Brown AK, Gramstrap-Petersen AL, Ibañez RM, Feldman SA, Miklos DB, Mackall CL, Davis KL, Frank M, Ramakrishna S, Muffly L. Schultz LM, et al. Among authors: davis kl. Leukemia. 2024 Mar 15. doi: 10.1038/s41375-024-02220-y. Online ahead of print. Leukemia. 2024. PMID: 38491306
Journals must expand access to peer review data.
Smith OM, Davis KL, Waterman R, Pizza RB, Mack C, Conway EE, Dobson KC, Foster B, Hristova AE, Jarvey JC, Nourn N, Davis CL. Smith OM, et al. Among authors: davis kl. Trends Ecol Evol. 2024 Apr;39(4):311-314. doi: 10.1016/j.tree.2024.02.003. Epub 2024 Mar 12. Trends Ecol Evol. 2024. PMID: 38472078
Inosine induces stemness features in CAR-T cells and enhances potency.
Klysz DD, Fowler C, Malipatlolla M, Stuani L, Freitas KA, Chen Y, Meier S, Daniel B, Sandor K, Xu P, Huang J, Labanieh L, Keerthi V, Leruste A, Bashti M, Mata-Alcazar J, Gkitsas N, Guerrero JA, Fisher C, Patel S, Asano K, Patel S, Davis KL, Satpathy AT, Feldman SA, Sotillo E, Mackall CL. Klysz DD, et al. Among authors: davis kl. Cancer Cell. 2024 Feb 12;42(2):266-282.e8. doi: 10.1016/j.ccell.2024.01.002. Epub 2024 Jan 25. Cancer Cell. 2024. PMID: 38278150 Free article.
Early Real-World Treatment Patterns and Clinical Outcomes in Patients with Metastatic Breast Cancer Treated with Eribulin After Prior Immuno-Oncology or Antibody-Drug Conjugate Therapy.
Goyal RK, Zhang J, Davis KL, Sluga-O'Callaghan M, Kaufman PA. Goyal RK, et al. Among authors: davis kl. Breast Cancer (Dove Med Press). 2023 Nov 17;15:855-865. doi: 10.2147/BCTT.S422025. eCollection 2023. Breast Cancer (Dove Med Press). 2023. PMID: 38020049 Free PMC article.
741 results